Close Menu

NEW YORK (GenomeWeb) – Sample prep firm Ceres Nanosciences said this week it has received a $430,000 grant from the Bill & Melinda Gates Foundation for development work on a saliva-based test for the Ebola virus.

The grant will fund feasibility studies investigating the usefulness of Ceres' Nanotrap technology for preparation of saliva samples upfront of both nucleic acid and protein-based assays for the disease. The studies will be conducted in collaboration with George Mason University and the US Army Medical Research Institutes of Infectious Diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.